Hodgkin Lymphoma

Filter By:
04:35
During the 2014 American Society of Hematology (ASH) annual meeting, Dr. Ajay Gopal from Seattle Cancer Care Alliance joined Patient Power to share exciting treatment news for lymphomas. He provided an overview of all the latest, including positive news about the oral therapy Zydelig® (idelalisib) i...
by:patientpower | 60 views
09:31
During the 2014 American Society of Hematology (ASH) annual meeting, Dr. Catherine Bollard from Children's National Health System joined Patient Power to share encouraging news for the treatment of the relapsed/refrac​tory lymphoma and acute lymphoblastic leukemia (ALL). Dr. Bollard discusses how exp...
by:patientpower | 126 views
04:12
During the 2014 American Society of Hematology (ASH) annual meeting, Dr. Philippe Armand from Dana-Farber Cancer Institute joined Patient Power to share some encouraging treatment news. He gave an explanation of checkpoint inhibitors and the PD-1 pathway related to treatment of blood cancers. Dr. Ar...
by:patientpower | 181 views
24:17
In this “Best of the Day” presentation from the 2014 Annual Hematology Meeting in San Francisco, Dr. Joseph R. Mikhael and Dr. John P. Leonard discuss pertinent clinical data and late breaking abstracts for the management of patients with lymphoma. This expert review and discussion covers therapeutic strategies for Hodgkin lymphoma, follicular lymp...
by:imedex | 137 views
23:32
At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Catherine Bollard (Children's National Medical Center, Washington, DC), Dr Philippe Armand (Dana-Farber Cancer Institute, Boston, MA), Dr Craig Moskowitz (Memorial Sloan Kettering Cancer Center, New York, NY), Dr Nicola Gökbuget (Un...
by:EMJ | 154 views
05:37
At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Joseph Alvarnas (City of Hope National Medical Center, Duarte, CA) presents data from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0803)/AIDS Malignancy Consortium (AMC-071) trial, which...
by:EMJ | 143 views
07:23
At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Craig Moskowitz (Memorial Sloan Kettering Cancer Center, New York, NY) presents results from the phase III AETHERA trial, which evaluated the safety and efficacy of brentuximab vedotin in preventing post-au...
by:EMJ | 189 views
05:53
At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Craig Moskowitz (Memorial Sloan Kettering Cancer Center, New York, NY) discusses the preliminary results of a phase Ib study evaluating the PD-1 inhibitor, pembrolizumab, in patients with classical Hodgkin ...
by:EMJ | 140 views
19:05
At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Brad Kahl (University of Wisconsin School of Medicine, Madison, WI), Dr Craig Moskowitz (Memorial Sloan Kettering Cancer Center, New York, NY), Dr Joseph Alvarnas (City of Hope National Medical Center, Duarte, CA), Prof Keith Stewar...
by:EMJ | 109 views
07:48
At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Philippe Armand (Dana-Farber Cancer Institute, Boston, MA) discusses the results of a phase I study evaluating the preliminary efficacy and safety of programmed cell death 1 (PD-1) inhibitor, nivolumab, in ...
by:EMJ | 386 views
Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Oncologist 
Different type of MD 
Nurse 
Other oncology Professional 
Patient/Advocate 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.


username:   password: remember me

Sign In

Username:
Password:
Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)